Cas 1291103-17-7,cyclo[L-Arginyl-glycyl-L-asparagyl-D-phenylalanyl-L-(εN-[3-(1-maleimido)propionyl])lysine] trifluoroacetate

1291103-17-7

Post Buying Request

Basic information

Product Name: cyclo[L-Arginyl-glycyl-L-asparagyl-D-phenylalanyl-L-(εN-[3-(1-maleimido)propionyl])lysine] trifluoroacetate
Synonyms: cyclo[L-Arginyl-glycyl-L-asparagyl-D-phenylalanyl-L-(εN-[3-(1-maleimido)propionyl])lysine] trifluoroacetate
CAS NO:1291103-17-7
Molecular Formula:
Molecular Weight: 868.824
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: cyclo[L-Arginyl-glycyl-L-asparagyl-D-phenylalanyl-L-(εN-[3-(1-maleimido)propionyl])lysine] trifluoroacetate(CAS DataBase Reference)
NIST Chemistry Reference: cyclo[L-Arginyl-glycyl-L-asparagyl-D-phenylalanyl-L-(εN-[3-(1-maleimido)propionyl])lysine] trifluoroacetate(1291103-17-7)
EPA Substance Registry System: cyclo[L-Arginyl-glycyl-L-asparagyl-D-phenylalanyl-L-(εN-[3-(1-maleimido)propionyl])lysine] trifluoroacetate(1291103-17-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1291103-17-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1291103-17-7 Suppliers

Recommended suppliers

1291103-17-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1291103-17-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,1,1,0 and 3 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1291103-17:
(9*1)+(8*2)+(7*9)+(6*1)+(5*1)+(4*0)+(3*3)+(2*1)+(1*7)=117
117 % 10 = 7
So 1291103-17-7 is a valid CAS Registry Number.

1291103-17-7Upstream product

55750-62-4 3-maleimidopropionic acid N-hydroxysuccinimide ester

1291103-17-7Downstream Products

1291103-17-7Relevant academic research and scientific papers

Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy

Kimura, Sadaaki,Masunaga, Shin-Ichiro,Harada, Tomohiro,Kawamura, Yasuo,Ueda, Satoshi,Okuda, Kensuke,Nagasawa, Hideko

, p. 1721 - 1728 (2011)

Boron-containing agents play a key role in successful boron neutron capture therapy (BNCT). Icosahedral boron cluster-Arg-Gly-Asp (RGD) peptide conjugates were designed, synthesized, and evaluated for the biodistribution to develop tumor-selective boron c

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1291103-17-7